Vaxxinity, Inc. ( VAXX) - Stock Earnings
VAXX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
VAXX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -18.4 million USD | 0 USD |
| 2023Q2 | -14.0 million USD | — USD |
| 2023Q3 | -13.1 million USD | — USD |
VAXX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -138.0 million USD | 66000 USD |
| 2022 | -75.2 million USD | -1000 USD |
| 2023 | -66.0 million USD | — USD |
VAXX
Price: $0
52 week price:
Earnings Per Share: -0.45 USD
P/E Ratio: -0.05
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 380403
Market Capitalization: 2.1 million